Elevance Health I…
USUSDElevance Health Inc (LSE:0HG8) — Medical Specialities. Anzahl der Börsen, an denen die Aktien des Unternehmens gehandelt werden: 2. Auf dieser Seite: Kurs und Chart, Dividenden, größte Aktionäre und Entwicklung der Aktienanzahl.
Über das Unternehmen
- Website
- elevancehealth.com
- Investor Relations
- ir.elevancehealth.com/
- Sektor
- Health Care · Medical Specialities
- Hauptsitz
- Indianapolis, United States
- CEO
- Gail Boudreaux
- Mitarbeiter
- 96 129
- Gegründet
- 1940
- Ausstehende Aktien
- 216.87 Mio. Stand 2026-07-10
- Streubesitz
- 216.37 Mio.
- Marktkapitalisierung
- 85.17 Mrd. USD
- Insider
- 0.19%
- Institutionelle Anleger
- 94.15%
- Branche (SIC)
- Hospital & Medical Service Plans
- ISIN
- US0367521038
- LEI
- 8MYN82XMYQH89CTMTH67
- Ausschüttungsquote
- 30.4%
- FCF
- 6.29 Mrd. USD
- Ausschüttung / FCF
- 24%
- Schulden
- 31.0 Mrd. USD3.3 J. FCF
- Dividendenserie
- 15 J.
- Gewinn, FCF und gezahlte Dividenden — für die 12 Monate bis 30.06.2026 (letzter Bericht des Unternehmens).
- NAV
Beschreibung
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Dividenden
Elevance Health Inc (ELV) zahlt vierteljährlich Dividenden. Pro Jahr (12 Monate bis einschließlich der zuletzt angekündigten Zahlung): 6.87 USD pro Aktie (Zahlungen: 4). Das entspricht etwa 1.60% des aktuellen Aktienkurses. Basierend auf der Zahlungshistorie wird der nächste Ex-Dividenden-Tag um den 10.12.2026 erwartet. Ununterbrochene Dividendengeschichte: 15 Jahre.
| Ex-tag | Auszahlung | Betrag | % | Typ | Ticker |
|---|---|---|---|---|---|
| 2026-09-10 | 2026-09-25 | 1.7200 USD | 0.4/1.7 % | vierteljährlich | US:ELV |
| 2026-06-10 | 2026-06-25 | 1.7200 USD | 0.4/1.6 % | vierteljährlich | US:ELV |
| 2026-03-10 | 2026-03-25 | 1.7200 USD | 0.6/2.4 % | vierteljährlich | US:ELV |
| 2025-12-05 | 2025-12-19 | 1.7100 USD | 0.5/2.1 % | vierteljährlich | US:ELV |
| 2025-09-10 | 2025-09-25 | 1.7100 USD | 0.5/2.1 % | vierteljährlich | US:ELV |
| 2025-06-10 | 2025-06-25 | 1.7100 USD | 0.4/1.7 % | vierteljährlich | US:ELV |
| 2025-03-10 | 2025-03-25 | 1.7100 USD | 0.4/1.6 % | vierteljährlich | US:ELV |
| 2024-12-05 | 2024-12-20 | 1.6300 USD | 0.4/1.6 % | vierteljährlich | US:ELV |
| 2024-09-10 | 2024-09-25 | 1.6300 USD | 0.4/1.5 % | vierteljährlich | US:ELV |
| 2024-06-10 | 2024-06-25 | 1.6300 USD | 0.4/1.4 % | vierteljährlich | US:ELV |
| 2024-03-07 | 2024-03-22 | 1.6300 USD | 0.4/1.4 % | vierteljährlich | US:ELV |
| 2023-12-05 | 2023-12-21 | 1.4800 USD | 0.3/1.4 % | vierteljährlich | US:ELV |
| 2023-09-07 | 2023-09-22 | 1.4800 USD | 0.3/1.3 % | vierteljährlich | US:ELV |
| 2023-06-08 | 2023-06-23 | 1.4800 USD | 0.3/1.3 % | vierteljährlich | US:ELV |
| 2023-03-09 | 2023-03-24 | 1.4800 USD | 0.3/1.2 % | vierteljährlich | US:ELV |
| 2022-12-02 | 2022-12-21 | 1.2800 USD | 0.3/1.2 % | vierteljährlich | US:ELV |
| 2022-09-08 | 2022-09-23 | 1.2800 USD | 0.3/1.2 % | vierteljährlich | US:ELV |
| 2022-06-09 | 2022-06-24 | 1.2800 USD | 0.3/0.9 % | vierteljährlich | US:ELV |
| 2022-03-09 | 2022-03-25 | 1.2800 USD | 0.3/0.6 % | vierteljährlich | US:ELV |
| 2021-12-02 | 2021-12-21 | 1.1300 USD | 0.3/0.3 % | vierteljährlich | US:ELV |
Größte Anteilseigner
| Inhaber | Anteil | Aktien | Berichtsdatum |
|---|---|---|---|
| Blackrock Inc. | 8.76% | 18.99 Mio. | 2026-06-30 |
| Vanguard Capital Managem… | 6.48% | 14.06 Mio. | 2026-06-30 |
| State Street Corporation | 4.81% | 10.43 Mio. | 2026-06-30 |
| Wellington Management Gr… | 4.25% | 9.21 Mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.05% | 6.61 Mio. | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.87% | 6.21 Mio. | 2026-06-30 |
| Sanders Capital, LLC | 2.69% | 5.83 Mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.49% | 5.39 Mio. | 2026-06-30 |
| Geode Capital Management… | 2.38% | 5.17 Mio. | 2026-06-30 |
| Harris Associates L.P. | 2.27% | 4.92 Mio. | 2026-06-30 |
| Artisan Partners Limited… | 2.11% | 4.58 Mio. | 2026-06-30 |
| Invesco Ltd. | 1.95% | 4.23 Mio. | 2026-06-30 |
| VANGUARD WINDSOR FUNDS-V… | 1.4% | 3.04 Mio. | 2026-07-31 |
| iShares Trust-iShares Co… | 1.33% | 2.89 Mio. | 2026-08-31 |
| First Eagle Funds-First… | 1.31% | 2.84 Mio. | 2026-07-31 |
| Fidelity Concord Street… | 1.29% | 2.81 Mio. | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.23% | 2.66 Mio. | 2026-08-31 |
| VANGUARD FENWAY FUNDS-Va… | 0.94% | 2.05 Mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.93% | 2.02 Mio. | 2026-06-30 |
| VANGUARD SPECIALIZED FUN… | 0.86% | 1.86 Mio. | 2026-07-31 |
| BOUDREAUX GAIL A KOZIARA… | ≈0.08% | 172 036 | 2026-07-17 |
| BOUDREAUX GAIL KOZIARA (… | ≈0.08% | 169 311 | 2026-03-02 |
| NORWOOD FELICIA F. (Offi… | ≈0.02% | 38 838 | 2026-03-02 |
| KAYE MARK (Chief Financi… | ≈0.01% | 32 037 | 2026-03-02 |
| HAYTAIAN PETER D (Office… | ≈0.01% | 27 222 | 2026-03-02 |
| LAVU RATNAKAR (Chief Tec… | ≈0.01% | 16 149 | 2026-03-02 |
| HAY LEWIS III (Director) | ≈0.01% | 12 070 | 2026-05-13 |
| KENDRICK CHARLES MORGAN… | ≈0.01% | 11 791 | 2026-03-06 |
| PERU RAMIRO G (Director) | ≈0.01% | 10 908 | 2026-07-17 |
| DIXON ROBERT L JR (Direc… | ≈0% | 10 734 | 2026-06-11 |
